Electric Moto Corporation (PINK:EMOT) reached up 63.64% in morning trading to $.018 with 5M shares traded. Electric Moto Corporation is a leading technology and lifestyle company dedicated to the development, production and distribution of zero emission vehicles and related products. The 72 Volt Dual Sport electric motorcycle leads the charge of EMOT's "Green" vehicles including an electric bicycle, ATV and personal watercraft. Electric Moto Corporation (Pinksheets:EMOT - News) announced today that it has begun conversations with government and industry leaders in the Dominican Republic regarding the manufacture and sales of its vehicles.
Javalution Coffee Company (PINK:JCOF) reached up 50% in morning trading to $.27 with 3M shares traded. Javalution Coffee Company is a fully vertical coffee roasting and distribution company, owner of the Direct Marketing Brand JavaFit, and the retail brand, Café La Rica, as well as the category creator of functional gourmet coffee. Javalution Coffee Company (Pinksheets:JCOF - News) announces an estimated annual $2,000,000 private label roasting deal between CLR Roasters, Javalution's wholly owned subsidiary, and Aldi, Inc. CLR Roasters will be providing 6 items including whole bean and ground coffees to 6 different divisions of Aldi stores, essentially being named Aldi's Southeastern Coffee Roaster. The contract will begin this month (May 2011).
ARCA biopharma, Inc. (Nasdaq:ABIO) reached up 36.70% in morning trading to $2.57 with 2M shares traded. ARCA biopharma is dedicated to developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate, GencaroTM (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker being developed for atrial fibrillation and heart failure. ARCA has identified common genetic variations that it believes predict individual patient response to Gencaro, giving it the potential to be the first genetically-targeted atrial fibrillation prevention and/or heart failure treatment. ARCA is collaborating with Laboratory Corporation of America to develop the companion genetic test for Gencaro. ARCA biopharma, Inc. (Nasdaq:ABIO - News) today announced that it has entered into an agreement with Novartis pursuant to which Novartis is acquiring global patent rights to an undisclosed molecular target. ARCA will receive an upfront payment of $2.0 million and is eligible to receive clinical, regulatory and commercial milestones totaling $17.5 million. Additional terms of the transaction were not disclosed.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
